Eli Lilly sued three medical spas and online vendors for selling products that claim to contain the ingredient in its ...

Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

While all state Medicaid programs cover GLP-1 agonists for type 2 diabetes, it’s much less common for them to cover the drugs ...

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...

To combat these alternative sellers, pharmaceutical company Eli Lilly began offering an alternative version of its brand-name ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

Xcel Wealth Management LLC reduced its holdings in Eli Lilly and Company (NYSE:LLY – Free Report) by 8.3% during the 3rd quarter, Holdings Channel reports. The fund owned 509 shares of the company’s ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best medical ...

In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as ...